Literature DB >> 18675357

Genetics of iron regulation and the possible role of iron in Parkinson's disease.

Shannon L Rhodes1, Beate Ritz.   

Abstract

Parkinson's disease (PD) is acknowledged as the second most common neurodegenerative disorder after Alzheimer's Disease. Older age may be the only unequivocal risk factor for PD although the male to female ratio is consistently greater than 1 in populations of European ancestry. Characteristic features of PD include dopaminergic neuron death in the substantia nigra (SN) pars compacta, accumulation of alpha-synuclein inclusions known as Lewy bodies in the SN, and brain iron accumulation beyond that observed in non-PD brains of a similar age. In this review article, we will provide an overview of human and animal studies investigating the contributions of iron in PD, a summary of human studies of iron-related genes in PD, a review of the literature on the genetics of iron metabolism, and some hypotheses on possible roles for iron in the pathogenic processes of PD including potential interactions between iron and other factors associated with Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18675357      PMCID: PMC3643980          DOI: 10.1016/j.nbd.2008.07.001

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  201 in total

Review 1.  Iron, neuroinflammation, and Alzheimer's disease.

Authors:  Wei-Yi Ong; Akhlaq A Farooqui
Journal:  J Alzheimers Dis       Date:  2005-11       Impact factor: 4.472

2.  The specific vulnerability of the substantia nigra to MPTP is related to the presence of transition metals.

Authors:  J Poirier; J Donaldson; A Barbeau
Journal:  Biochem Biophys Res Commun       Date:  1985-04-16       Impact factor: 3.575

3.  Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study.

Authors:  M D Benedetti; D M Maraganore; J H Bower; S K McDonnell; B J Peterson; J E Ahlskog; D J Schaid; W A Rocca
Journal:  Mov Disord       Date:  2001-09       Impact factor: 10.338

4.  Prevention of neuroleptic-induced dopamine D2 receptor supersensitivity by chronic iron salt treatment.

Authors:  D Ben-Shachar; B Pinhassi; M B Youdim
Journal:  Eur J Pharmacol       Date:  1991-09-17       Impact factor: 4.432

5.  Detection and isolation of a hepatic membrane receptor for ferritin.

Authors:  U Mack; L W Powell; J W Halliday
Journal:  J Biol Chem       Date:  1983-04-25       Impact factor: 5.157

6.  Binding of iron to neuromelanin of human substantia nigra and synthetic melanin: an electron paramagnetic resonance spectroscopy study.

Authors:  T Shima; T Sarna; H M Swartz; A Stroppolo; R Gerbasi; L Zecca
Journal:  Free Radic Biol Med       Date:  1997       Impact factor: 7.376

7.  TorsinA accumulation in Lewy bodies in sporadic Parkinson's disease.

Authors:  P Shashidharan; P F Good; A Hsu; D P Perl; M F Brin; C W Olanow
Journal:  Brain Res       Date:  2000-09-22       Impact factor: 3.252

8.  The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation.

Authors:  Gaël Nicolas; Caroline Chauvet; Lydie Viatte; Jean Louis Danan; Xavier Bigard; Isabelle Devaux; Carole Beaumont; Axel Kahn; Sophie Vaulont
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

9.  The significance of the mutated divalent metal transporter (DMT1) on iron transport into the Belgrade rat brain.

Authors:  Torben Moos; Evan H Morgan
Journal:  J Neurochem       Date:  2004-01       Impact factor: 5.372

10.  The Cys282Tyr polymorphism in the HFE gene in Australian Parkinson's disease patients.

Authors:  D D Buchanan; P A Silburn; J B Chalk; D G Le Couteur; G D Mellick
Journal:  Neurosci Lett       Date:  2002-07-19       Impact factor: 3.046

View more
  39 in total

Review 1.  Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: no.

Authors:  Uwe Walter
Journal:  J Neural Transm (Vienna)       Date:  2010-12-29       Impact factor: 3.575

2.  Angiotensin II inhibits iron uptake and release in cultured neurons.

Authors:  Yong Liu; Suna Huang; Fang Du; Guang Yang; Li Rong Jiang; Chao Zhang; Zhong-ming Qian
Journal:  Neurochem Res       Date:  2014-03-30       Impact factor: 3.996

3.  Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century.

Authors:  Wing-Hin Lee; Ching-Yee Loo; Mary Bebawy; Frederick Luk; Rebecca S Mason; Ramin Rohanizadeh
Journal:  Curr Neuropharmacol       Date:  2013-07       Impact factor: 7.363

4.  Pooled analysis of iron-related genes in Parkinson's disease: association with transferrin.

Authors:  Shannon L Rhodes; Daniel D Buchanan; Ismaïl Ahmed; Kent D Taylor; Marie-Anne Loriot; Janet S Sinsheimer; Jeff M Bronstein; Alexis Elbaz; George D Mellick; Jerome I Rotter; Beate Ritz
Journal:  Neurobiol Dis       Date:  2013-10-08       Impact factor: 5.996

5.  Regulation of quinolinic acid neosynthesis in mouse, rat and human brain by iron and iron chelators in vitro.

Authors:  Erin K Stachowski; Robert Schwarcz
Journal:  J Neural Transm (Vienna)       Date:  2011-08-11       Impact factor: 3.575

6.  Insulin resistance impairs nigrostriatal dopamine function.

Authors:  J K Morris; G L Bomhoff; B K Gorres; V A Davis; J Kim; P-P Lee; W M Brooks; G A Gerhardt; P C Geiger; J A Stanford
Journal:  Exp Neurol       Date:  2011-06-15       Impact factor: 5.330

Review 7.  Iron chelation and neuroprotection in neurodegenerative diseases.

Authors:  Xuping Li; Joseph Jankovic; Weidong Le
Journal:  J Neural Transm (Vienna)       Date:  2010-12-16       Impact factor: 3.575

8.  T1rho and T2rho MRI in the evaluation of Parkinson's disease.

Authors:  I Nestrasil; S Michaeli; T Liimatainen; C E Rydeen; C M Kotz; J P Nixon; T Hanson; Paul J Tuite
Journal:  J Neurol       Date:  2010-01-08       Impact factor: 4.849

9.  Association between α-synuclein blood transcripts and early, neuroimaging-supported Parkinson's disease.

Authors:  Joseph J Locascio; Shirley Eberly; Zhixiang Liao; Ganqiang Liu; Ashley N Hoesing; Karen Duong; Ana Trisini-Lipsanopoulos; Kaltra Dhima; Albert Y Hung; Alice W Flaherty; Michael A Schwarzschild; Michael T Hayes; Anne-Marie Wills; U Shivraj Sohur; Nicte I Mejia; Dennis J Selkoe; David Oakes; Ira Shoulson; Xianjun Dong; Ken Marek; Bin Zheng; Adrian Ivinson; Bradley T Hyman; John H Growdon; Lewis R Sudarsky; Michael G Schlossmacher; Bernard Ravina; Clemens R Scherzer
Journal:  Brain       Date:  2015-07-28       Impact factor: 13.501

Review 10.  Systems genetics analysis of iron regulation in the brain.

Authors:  Leslie C Jellen; John L Beard; Byron C Jones
Journal:  Biochimie       Date:  2009-04-22       Impact factor: 4.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.